Latest News and Press Releases

GeneDx (Nasdaq: WGS) today announced it will release financial results for the second quarter of 2024 after the market closes on Tuesday, July 30, 2024.

-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on...

STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient...

GeneDx (Nasdaq: WGS) today announced that company management will participate in two upcoming investor conferences in June.

GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the first quarter of 2024.

STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with...

Management will host a conference call on Monday, April 29, 2024 to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time.

STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at...

GeneDx (Nasdaq: WGS) today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA.

GeneDx Holdings Corp. (Nasdaq: WGS) reported its financial results for the fourth quarter and full year of 2023.